Clinical Trials Sponsored by Scandinavian Breast Group

Total 327 results

SOLTI Breast Cancer Research Group
Roche Pharma AG

Recruiting

Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients (IPATHER)

Metastatic Breast Cancer

Spain
Samsung Medical Center
Korean Breast Cancer Study Group

Recruiting

Omitting vs. Doing Intraoperative Frozen Section Biopsy for Margin Status in Breast Conserving Surgery (OFF-MAP)

Breast Cancer

Korea, Republic of
SOLTI Breast Cancer Research Group
Daiichi Sankyo, Inc.

Active, not recruiting

NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE Trial (VALENTINE)

Breast Cancer

Spain
Spanish Breast Cancer Research Group
Bristol-Myers Squibb

Completed

Dasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC Patients

Metastatic Breast Cancer

Spain
Spanish Breast Cancer Research Group
Roche Farma, S.A

Completed

Evaluation of Degree of Conversion of HER2 Receptor Between Primary Breast Cancer and Metastasis

Breast Cancer

Spain
SOLTI Breast Cancer Research Group
Radius Health, Inc.

Completed

Elacestrant in Preoperative Setting, a Window of Opportunity Study (ELIPSE)

Breast Cancer | Hormone Receptor Positive Breast Carcinoma

Spain
Danish Breast Cancer Cooperative Group
Danish Cancer Society

Active, not recruiting

Hypofractionated Versus Standard Fractionated Whole Breast Irradiation to Node-negative Breast Cancer Patients

Breast Cancer | Carcinoma in Situ of the Breast

Denmark
Spanish Breast Cancer Research Group
Hoffmann-La Roche

Terminated

Benefit of Adding Trastuzumab to Second Line Chemotherapy in Breast Cancer Patients Previously Treated With Trastuzumab

Breast Cancer

Spain
Martin-Luther-Universität Halle-Wittenberg
German Breast Group

Unknown

6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer Patients (NNBC3-Europe)

Breast Cancer

Germany
University of Aarhus
Danish Breast Cancer Cooperative Group

Unknown

Feasibility and Efficacy of Internet-delivered CBT for Insomnia in a National Cohort of Danish Breast Cancer Survivors

Insomnia

Denmark
SOLTI Breast Cancer Research Group
Sysmex America, Inc.

Completed

Sentinel Lymph Node Total Tumoral Load as a Predictor of Non Sentinel Node Involvement in Early Breast Cancer (SOLO-1)

Breast Cancer

Spain
Asan Medical Center
Korean Breast Cancer Study Group

Unknown

Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer (NEST)

Breast Cancer

Korea, Republic of
Regional Oncologic Center
European Organisation for Research and Treatment of Cancer - EORTC; Scandinavian... and other collaborators

Completed

Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer

Breast Cancer | Menopausal Symptoms

Finland, Norway, Poland, Sweden, Switzerland
SOLTI Breast Cancer Research Group
Daiichi Sankyo, Inc.

Recruiting

HER2-PREDICT: Translational Study of Tumor Samples From Patients Treated With Trastuzumab Deruxtecan (T-DXd; DS-8201a) (HER2-PREDICT)

Metastatic Cancer

Spain
Austrian Breast & Colorectal Cancer Study Group
Oberösterreichische Krebshilfe

Recruiting

ABCSG C08-Exercise II: Trial of Endurance Exercise Following Adjuvant Chemotherapy for Colorectal Cancer (ABCSG C08)

Colorectal Carcinoma

Austria
Japan Breast Cancer Research Group
Eisai Co., Ltd.

Recruiting

A Study to Compare Eribulin Mesylate + Pertuzumab + Trastuzumab With Paclitaxel or Docetaxel + Pertuzumab + Trastuzumab

Breast Cancer

Japan
Lund University Hospital
South Sweden Breast Cancer Group

Recruiting

A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer (ABC-SE)

Breast Cancer

Sweden
Amgen
Austrian Breast and Colorectal Cancer Study Group

Completed

Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy

Breast Cancer

Austria, Sweden
Spanish Breast Cancer Research Group
Roche Farma, S.A

Completed

Unraveling KAdcyla Resistance In Human Epidermal Growth Factor Receptor 2(HER2) Positive Advanced Breast Cancer (KATIA) (KATIA)

Advanced Breast Cancer

Spain
Spanish Breast Cancer Research Group
Roche Farma, S.A

Completed

Evaluation of Hypertension as a Predictor of Efficacy Bevacizumab in Metastatic Breast Cancer and Colorectal Cancer (BRECOL)

Metastatic Colorectal Cancer | Metastatic Breast Cancer

Spain
Spanish Breast Cancer Research Group
Hoffmann-La Roche

Terminated

Capecitabine Plus Radiotherapy for Local Relapse Breast Cancer With Negative Her2 Tumours

Breast Cancer

Spain
Breast Cancer Trials, Australia and New Zealand
ETOP IBCSG Partners Foundation; Breast International Group

Recruiting

EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer (EXPERT)

Early Stage Breast Carcinoma

Taiwan, Australia, Spain, New Zealand, Ireland, Italy, Argentina, Switzerland, Chile
European Organisation for Research and Treatment...
Australasian Gastro-Intestinal Trials Group; Italian Sarcoma Group; Scandinavian...

Unknown

Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor

Gastrointestinal Stromal Tumor
University Hospital, Brest
Tyco Healthcare Group

Completed

Efficacy of Intermittent Pneumatic Compression (IPC) on Venous Thromboembolism Incidence in Intensive Care Unit (ICU) Patients With High Bleeding Risk (CIREA1)

Hemorrhage | High Bleeding Risk

France
Australasian Gastro-Intestinal Trials Group
European Organisation for Research and Treatment of Cancer - EORTC; Scandinavian...

Active, not recruiting

A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST) (ALT GIST)

Gastrointestinal Stromal Tumour

Singapore, Norway, Finland, Australia, Sweden, France, United Kingdom, Spain, Netherlands, Slovakia
Alliance Foundation Trials, LLC.
Pfizer; Breast International Group; NSABP Foundation Inc; Austrian Breast & Colorectal... and other collaborators

Active, not recruiting

PALbociclib CoLlaborative Adjuvant Study (PALLAS)

Breast Cancer

United States, Spain, Italy, Ireland, United Kingdom, Australia, Germany, Japan, Portugal, Taiwan, Canada, Israel, Netherlands, Switzerland, Belgium, Austria, Hungary, Korea, Republic of, Mexico, Poland, Sweden
European Organisation for Research and Treatment...
Hellenic Oncology Research Group; Latin American Cooperative Oncology Group; Hellenic... and other collaborators

Active, not recruiting

Male Breast Cancer: Understanding the Biology for Improved Patient Care

Breast Cancer

United States, Ireland, United Kingdom, Belgium, Switzerland, Spain, Poland, Greece, Portugal, Egypt, Brazil, Mexico, Netherlands, Peru, Serbia, Sweden
German Breast Group
Pfizer; AMS Advanced Medical Services GmbH

Recruiting

A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study). (PADMA)

Metastatic Breast Cancer

Germany
Spanish Breast Cancer Research Group
Eli Lilly and Company

Completed

Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients

Breast Cancer | Neoplasm Metastasis

Spain, Venezuela
ITF Research Pharma, S.L.U.
Spanish Breast Cancer Research Group

Completed

A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting (BLISSAFE)

Vaginal Atrophy

Spain, Sweden
Ontario Clinical Oncology Group (OCOG)
Canadian Breast Cancer Initiative

Completed

Randomized Trial of Follow-up Strategies in Breast Cancer

Breast Cancer

Canada
Austrian Breast & Colorectal Cancer Study Group
Pharmacia Austria GmbH

Completed

Neoadjuvant Endocrinotherapy of Breast Cancer (Mamma Carcinoma) With Exemestane

Breast Cancer

Austria
AstraZeneca
Austrian Breast and Colorectal Cancer Study Group (ABCSG)

Recruiting

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) (CAMBRIA-2)

Breast Cancer, Early Breast Cancer

United States, Spain, Italy, Korea, Republic of, Belgium, Canada, Poland, Portugal, United Kingdom, France, China, Germany, Japan, Mexico, Thailand, Hungary, Australia, Austria, Brazil, Colombia, Taiwan, Malaysia, Philippines, Romania, ... and more
SOLTI Breast Cancer Research Group
Merck Sharp & Dohme LLC

Terminated

Pembrolizumab + Paclitaxel in Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2-negative (HER2-) Non-luminal (by PAM50) Advanced Breast Cancer After Cyclin-dependent Kinase 4/6 (CDK4/6) Inhibitors Progression (TATEN)

Metastatic Breast Cancer

Spain
Ontario Clinical Oncology Group (OCOG)
Canadian Breast Cancer Foundation

Completed

Trial of Radiation Fractionation Schedules for Once-a-Day Accelerated Partial Breast Irradiation (OPAR)

Breast Cancer | DCIS

Canada
Spanish Breast Cancer Research Group
Merck Sharp & Dohme LLC

Completed

Trial to Evaluate Efficacy and Safety of Pembrolizumab and Gemcitabine in HER2-negative ABC (PANGEA)

Advanced Breast Cancer

Spain
Institut de Recherches Internationales Servier
Breast International Group

Completed

A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer (FINESSE)

Breast Cancer

United Kingdom, Italy, France, Belgium, Australia, Canada, Germany, Hungary, Spain
Austrian Breast & Colorectal Cancer Study Group
Hoffmann-La Roche

Completed

Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy

Rectal Cancer

Austria
Danish Breast Cancer Cooperative Group
Sanofi; Hoffmann-La Roche

Unknown

Vinorelbine Plus (+) Trastuzumab vs Docetaxel Plus (+) Trastuzumab as 1 Line Treatment for HER2 Positive (+) Metastatic Breast Cancer

Breast Cancer

Denmark
University of Rostock
German Breast Group; German Cancer Aid

Active, not recruiting

Comparison of Axillary Sentinel Lymph Node Biopsy Versus no Axillary Surgery (INSEMA)

Breast Cancer

Austria, Germany
Hoffmann-La Roche
NSABP Foundation Inc; German Breast Group

Active, not recruiting

A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)

Breast Cancer

United States, Italy, United Kingdom, Canada, Czechia, Argentina, Austria, Belgium, Brazil, China, France, Germany, Guatemala, Ireland, Panama, Spain, Sweden, Taiwan, Turkey, Colombia, Hong Kong, Peru, Switzerland, South Africa, Israel, G... and more
Austrian Breast & Colorectal Cancer Study Group
AstraZeneca; Novartis Pharmaceuticals

Completed

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

Breast Cancer

Austria, Germany
Spanish Breast Cancer Research Group
Eli Lilly and Company

Active, not recruiting

Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients (CARABELA)

Early Breast Cancer

Spain
SOLTI Breast Cancer Research Group
Roche Pharma AG; Amgen

Active, not recruiting

Combination of Talimogene Laherparepvec With Atezolizumab in Early Breast Cancer (PROMETEO)

Breast Cancer

Spain
Spanish Breast Cancer Research Group
Merck Sharp & Dohme LLC

Completed

Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer.

Breast Cancer

Spain
Austrian Breast & Colorectal Cancer Study Group
Hoffmann-La Roche

Terminated

Preoperative Combined RadioChemo-Molecular Target Therapy With Capecitabine, Bevacizumab, and Radiotherapy

Rectal Cancer

Austria
Finnish Breast Cancer Group
Sanofi; Hoffmann-La Roche; AstraZeneca

Completed

Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer

Breast Cancer

Finland
European Organisation for Research and Treatment...
Pfizer; ETOP IBCSG Partners Foundation; UNICANCER; Breast International Group; SOLTI... and other collaborators

Active, not recruiting

Adjuvant Palbociclib in Elderly Patients With Breast Cancer (Appalaches)

Breast Cancer Stage II | Breast Cancer Stage III

Spain, France, Italy, Belgium, Jordan, Poland, Germany, United Kingdom, Portugal
Spanish Breast Cancer Research Group
Hoffmann-La Roche; IBEROAMERICAN COALITION FOR BREAST ONCOLOGY RESEARCH (CIBOMA)

Completed

Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer Patients

Breast Cancer

Spain
Alliance Foundation Trials, LLC.
Pfizer; Syneos Health; UNICANCER; German Breast Group; SOLTI Breast Cancer Research... and other collaborators

Active, not recruiting

Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer (PATINA)

HER-2 Positive Breast Cancer | Estrogen Receptor Positive Breast Cancer

United States, Spain, France, Italy, Germany, Australia, Portugal, New Zealand

Clinical Trials Sponsored by Scandinavian Breast Group

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations